Soft tissue / musculoskeletaal
Sarcoma
Activity of sunitinib in esophageal cancer, melanoma and sarcoma. SEMS VUB08001 Investigation of candidate predictive biomarkers for efficacy of sunitinib malate in patients with advanced oesophageal cancer, melanoma and sarcoma.
-
Study Phase II
Advanced Disease
A randomized discontinuation study of Brivanib alaninate (BMS-582664) versus Placebo in Subjets with advanced tumors.
- Study Phase II
- Gesloten voor pancreas, blaas, maag en slokdarm
- Selection criteria